Mutations in BHD and TP53 genes, but not in HNF1beta gene, in a large series of sporadic chromophobe renal cell carcinoma
about
A review on hepatocyte nuclear factor-1beta and tumorGenetic and Chromosomal Aberrations and Their Clinical Significance in Renal NeoplasmsGenomics of chromophobe renal cell carcinoma: implications from a rare tumor for pan-cancer studiesBirt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression.Systemic therapy for metastatic non-clear-cell renal cell carcinoma: recent progress and future directions.Folliculin, the product of the Birt-Hogg-Dube tumor suppressor gene, interacts with the adherens junction protein p0071 to regulate cell-cell adhesion.Signaling pathways in renal cell carcinoma.Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.Epigenetics of kidney cancer and bladder cancer.Clinical Features, Genetics and Potential Therapeutic Approaches for Birt-Hogg-Dubé Syndrome.Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeuticsp53 and MDM2 in renal cell carcinoma: biomarkers for disease progression and future therapeutic targets?Antitumor Response to Combined Antiangiogenic and Cytotoxic Chemotherapy in Recurrent Metastatic Chromophobe Renal Cell Carcinoma: Response Signatures and Proteomic Correlates.The UOK 257 cell line: a novel model for studies of the human Birt-Hogg-Dubé gene pathway.mTOR pathway in renal cell carcinoma.Hereditary kidney cancer: unique opportunity for disease-based therapy.Molecular genetics and clinical features of Birt-Hogg-Dubé syndrome.Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeuticsKidney cancer pathology in the new context of targeted therapy.New insights into the management of renal cell cancer.Transition of organizational category on renal cancer.Tumour and patient factors in renal cell carcinoma-towards personalized therapy.Renal cell cancers: unveiling the hereditary ones and saving lives-a tailored diagnostic approach.Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma.Heterozygous inactivation of tsc2 enhances tumorigenesis in p53 mutant zebrafish.Renal cell carcinoma histological subtype distribution differs by age, gender, and tumor size in coastal Chinese patients.FLCN: The causative gene for Birt-Hogg-Dubé syndrome.Renal Cell Carcinoma: Molecular Aspects
P2860
Q26783312-D40DF806-389F-4D83-ABE8-755C7B22291AQ26785930-61005F96-3ED0-4DED-9866-E7F51FAD5594Q26851787-0E1DFED6-5B3D-413C-A149-5C2B952D8995Q33772820-0A4FCDA6-AEED-463B-8794-1CC7B680B881Q34206531-2E87E4C7-36CE-4462-8C5E-027C12B3784EQ34471857-D0F3FBD9-42B1-429A-B9A9-C401C0DA947FQ34978827-E67B188C-720A-4D56-9E3C-23E7A4EEF3EEQ35223894-CC03BAF1-7405-47A6-8A75-55795EA27160Q35810625-1164D28A-302B-4F3B-B9C9-92036224FDCCQ35857807-3C0C387F-082C-49C1-8F32-440F9CDA3FDCQ36283086-04B2A8D5-78F6-411A-92DF-111FF21FA436Q36354841-79A01800-1DB0-4885-A938-B7D868F33B80Q36507052-B304CD30-24B6-47F9-952B-5903CB5ABAC2Q36665125-EB5BB73C-25A5-4AFB-A21E-25F293AAD5D5Q36737674-974391B2-D03E-484E-9EB0-849C92EBB251Q37086022-4EE4F4D6-A64A-45FF-B000-7375BA5C3DE9Q37287088-0FCF7227-E581-4F32-81A8-3DAE1E22768CQ37429054-67203D1F-D907-4D69-B5C2-D41862C43202Q37785109-DB0FCA14-4651-446A-A9C7-6CC68669B565Q37890209-7F1DD5B1-53AD-4245-8CCE-F56EC9CF90E3Q38053049-A52D262F-0693-4595-862B-F45AD2213549Q38079812-0E7313CA-589D-4247-9ACC-5C08C2D7127EQ38418649-CFE85C6D-6B0B-48B0-B371-B4ECC5418E66Q39343068-277A3D8F-EABD-425C-8244-CC4D2143CEE0Q39604051-AA832CB3-5177-4726-969E-7D308BF17D34Q42111573-7A99D722-4804-46E6-AFBE-67A92D454BB3Q42700879-30A8E497-9BE7-4A60-A522-E1ED519A702BQ47712748-1623D1F3-0B8B-4E35-8B3E-13EF1D68C9AEQ57178229-78EB90A1-383E-42D5-9B51-D9E908C48C6B
P2860
Mutations in BHD and TP53 genes, but not in HNF1beta gene, in a large series of sporadic chromophobe renal cell carcinoma
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Mutations in BHD and TP53 gene ...... romophobe renal cell carcinoma
@ast
Mutations in BHD and TP53 gene ...... romophobe renal cell carcinoma
@en
type
label
Mutations in BHD and TP53 gene ...... romophobe renal cell carcinoma
@ast
Mutations in BHD and TP53 gene ...... romophobe renal cell carcinoma
@en
prefLabel
Mutations in BHD and TP53 gene ...... romophobe renal cell carcinoma
@ast
Mutations in BHD and TP53 gene ...... romophobe renal cell carcinoma
@en
P2093
P2860
P356
P1476
Mutations in BHD and TP53 gene ...... romophobe renal cell carcinoma
@en
P2093
A Vieillefond
B Bressac-de Paillerets
S Ferlicot
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603492
P407
P577
2006-11-28T00:00:00Z
P5875
P6179
1040326199